Published in Mol Microbiol on June 01, 2002
Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A (2004) 5.34
An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A (2006) 3.89
Pathogenicity islands in bacterial pathogenesis. Clin Microbiol Rev (2004) 3.77
Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol (2003) 3.35
Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A (2009) 3.17
Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev (2003) 2.01
Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun (2006) 2.01
Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun (2004) 1.95
Precise excision of the large pathogenicity island, SPI7, in Salmonella enterica serovar Typhi. J Bacteriol (2004) 1.80
The ETT2 gene cluster, encoding a second type III secretion system from Escherichia coli, is present in the majority of strains but has undergone widespread mutational attrition. J Bacteriol (2004) 1.60
Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect Immun (2005) 1.51
A mosaic pathogenicity island made up of the locus of enterocyte effacement and a pathogenicity island of Escherichia coli O157:H7 is frequently present in attaching and effacing E. coli. Infect Immun (2003) 1.43
Instability of pathogenicity islands in uropathogenic Escherichia coli 536. J Bacteriol (2004) 1.37
Whole-genome phylogeny of Escherichia coli/Shigella group by feature frequency profiles (FFPs). Proc Natl Acad Sci U S A (2011) 1.36
EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect Immun (2005) 1.32
Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect Immun (2005) 1.29
Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis. J Clin Microbiol (2005) 1.25
Contribution of long polar fimbriae to the virulence of rabbit-specific enteropathogenic Escherichia coli. Infect Immun (2004) 1.20
Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J Bacteriol (2008) 1.18
The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536. Infect Immun (2004) 1.18
Nucleotide sequence and evolution of the five-plasmid complement of the phytopathogen Pseudomonas syringae pv. maculicola ES4326. J Bacteriol (2004) 1.13
Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect Immun (2004) 1.12
Localization of the insertion site and pathotype determination of the locus of enterocyte effacement of shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol (2004) 1.11
Systematic identification and sequence analysis of the genomic islands of the enteropathogenic Escherichia coli strain B171-8 by the combined use of whole-genome PCR scanning and fosmid mapping. J Bacteriol (2008) 1.11
Chromosomal instability in enterohaemorrhagic Escherichia coli O157:H7: impact on adherence, tellurite resistance and colony phenotype. Mol Microbiol (2011) 1.07
Microarray analyses of Xylella fastidiosa provide evidence of coordinated transcription control of laterally transferred elements. Genome Res (2003) 1.05
Comparative analysis of the locus of enterocyte effacement and its flanking regions. Infect Immun (2009) 1.02
In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med (2013) 0.99
Mouse model of enteropathogenic Escherichia coli infection. Infect Immun (2005) 0.99
Phylogenetic and molecular analysis of food-borne shiga toxin-producing Escherichia coli. Appl Environ Microbiol (2013) 0.96
Genomic diversity of pathogenic Escherichia coli of the EHEC 2 clonal complex. BMC Genomics (2009) 0.94
Comparative analysis of argK-tox clusters and their flanking regions in phaseolotoxin-producing Pseudomonas syringae pathovars. J Mol Evol (2006) 0.93
Genomic diversity of EPEC associated with clinical presentations of differing severity. Nat Microbiol (2016) 0.91
Sequence analysis of the Escherichia coli O15 antigen gene cluster and development of a PCR assay for rapid detection of intestinal and extraintestinal pathogenic E. coli O15 strains. J Clin Microbiol (2005) 0.90
Secretion of flagellin by the LEE-encoded type III secretion system of enteropathogenic Escherichia coli. BMC Microbiol (2009) 0.89
Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines. Microbiol Mol Biol Rev (2013) 0.87
Genome dynamics and its impact on evolution of Escherichia coli. Med Microbiol Immunol (2010) 0.83
Mobilisation and remobilisation of a large archetypal pathogenicity island of uropathogenic Escherichia coli in vitro support the role of conjugation for horizontal transfer of genomic islands. BMC Microbiol (2011) 0.82
RegR virulence regulon of rabbit-specific enteropathogenic Escherichia coli strain E22. Infect Immun (2013) 0.81
Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition. Infect Immun (2015) 0.81
Active genetic elements present in the locus of enterocyte effacement in Escherichia coli O26 and their role in mobility. Infect Immun (2006) 0.80
EHEC Adhesins. Microbiol Spectr (2015) 0.77
The role of lymphostatin/EHEC factor for adherence-1 in the pathogenesis of gram negative infection. Toxins (Basel) (2010) 0.77
Control of bacterial virulence by the RalR regulator of the rabbit-specific enteropathogenic Escherichia coli strain E22. Infect Immun (2013) 0.76
Identification of antibiotic resistance genes in the multidrug-resistant Acinetobacter baumannii strain, MDR-SHH02, using whole-genome sequencing. Int J Mol Med (2016) 0.75
Predominance of afr2 and ral fimbrial genes related to those encoding the K88 and CS31A fimbrial adhesins in enteropathogenic Escherichia coli isolates from rabbits with postweaning diarrhea in Central Europe. J Clin Microbiol (2005) 0.75
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Probiotic use in clinical practice: what are the risks? Am J Clin Nutr (2006) 2.44
Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med (2002) 2.38
Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun (2003) 2.22
Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg Infect Dis (2006) 2.19
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03
Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. Infect Immun (2002) 2.01
Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun (2006) 2.01
Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis (2012) 1.98
Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med (2006) 1.91
Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J (2010) 1.87
Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A (2002) 1.78
NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cells. Nat Immunol (2012) 1.62
Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med (2014) 1.60
Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun (2002) 1.54
Discovery of an archetypal protein transport system in bacterial outer membranes. Nat Struct Mol Biol (2012) 1.41
MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression. PLoS Pathog (2011) 1.36
Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem (2007) 1.33
Secretory antibodies do not affect the composition of the bacterial microbiota in the terminal ileum of 10-week-old mice. Appl Environ Microbiol (2003) 1.32
Pathogenicity of Yersinia enterocolitica biotype 1A. FEMS Immunol Med Microbiol (2003) 1.32
Control of bacterial virulence by AraC-like regulators that respond to chemical signals. Trends Microbiol (2011) 1.32
Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur J Immunol (2005) 1.29
Contribution of Efa1/LifA to the adherence of enteropathogenic Escherichia coli to epithelial cells. Microb Pathog (2003) 1.26
Bicarbonate-mediated transcriptional activation of divergent operons by the virulence regulatory protein, RegA, from Citrobacter rodentium. Mol Microbiol (2008) 1.24
Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans. Clin Infect Dis (2003) 1.23
Contribution of long polar fimbriae to the virulence of rabbit-specific enteropathogenic Escherichia coli. Infect Immun (2004) 1.20
Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg Infect Dis (2009) 1.18
The multi-copper-ion oxidase CueO of Salmonella enterica serovar Typhimurium is required for systemic virulence. Infect Immun (2010) 1.17
Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum. J Nat Prod (2003) 1.17
Phasevarion mediated epigenetic gene regulation in Helicobacter pylori. PLoS One (2011) 1.13
Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol (2012) 1.12
RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium. Infect Immun (2008) 1.11
Characterisation of atypical enteropathogenic E. coli strains of clinical origin. BMC Microbiol (2009) 1.11
The H-NS protein represses transcription of the eltAB operon, which encodes heat-labile enterotoxin in enterotoxigenic Escherichia coli, by binding to regions downstream of the promoter. Microbiology (2005) 1.10
In vitro oncosphere-killing assays to determine immunity to the larvae of Taenia pisiformis, Taenia ovis, Taenia saginata, and Taenia solium. J Parasitol (2006) 1.09
Factors that explain excretion of enteric pathogens by persons without diarrhea. Clin Infect Dis (2012) 1.09
CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect Immun (2006) 1.08
Influenza virus induces bacterial and nonbacterial otitis media. J Infect Dis (2011) 1.08
Role of the polymeric Ig receptor in mucosal B cell homeostasis. J Immunol (2003) 1.07
Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun (2007) 1.07
Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl Environ Microbiol (2006) 1.06
The reducible complexity of a mitochondrial molecular machine. Proc Natl Acad Sci U S A (2009) 1.05
Spatially resolved force spectroscopy of bacterial surfaces using force-volume imaging. Colloids Surf B Biointerfaces (2007) 1.04
Enteric pathogens, intestinal permeability and nitric oxide production in acute gastroenteritis. Pediatr Infect Dis J (2002) 1.03
Secretory antibodies reduce systemic antibody responses against the gastrointestinal commensal flora. Int Immunol (2007) 1.03
Contribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infections. Proc Natl Acad Sci U S A (2013) 1.02
Transcriptional regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM cluster, encoding the type II secretion pathway in enterotoxigenic Escherichia coli. J Bacteriol (2006) 1.02
Homologues of insecticidal toxin complex genes in Yersinia enterocolitica biotype 1A and their contribution to virulence. Infect Immun (2005) 1.01
Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect Immun (2008) 1.01
Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine (2013) 1.00
Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli. Infect Immun (2005) 1.00
The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli. Infect Immun (2012) 0.99
Fimbrial adhesins produced by atypical enteropathogenic Escherichia coli strains. Appl Environ Microbiol (2011) 0.99
Effects of inner ear trauma on the risk of pneumococcal meningitis. Arch Otolaryngol Head Neck Surg (2007) 0.98
Assembly of the type II secretion system such as found in Vibrio cholerae depends on the novel Pilotin AspS. PLoS Pathog (2013) 0.98
A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell Microbiol (2007) 0.98
Pneumococcal meningitis threshold model: A potential tool to assess infectious risk of new or existing inner ear surgical interventions. Otol Neurotol (2006) 0.98
Bicarbonate-mediated stimulation of RegA, the global virulence regulator from Citrobacter rodentium. J Mol Biol (2009) 0.97
Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiol (2008) 0.97
The relentless evolution of pathogenic Escherichia coli. Clin Infect Dis (2005) 0.97
Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J Clin Microbiol (2011) 0.96
Virulence regulation in Citrobacter rodentium: the art of timing. Microb Biotechnol (2009) 0.96
Multilocus sequence typing of Streptococcus pneumoniae by use of mass spectrometry. J Clin Microbiol (2011) 0.96
Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. J Clin Microbiol (2006) 0.95
Contribution of the pst-phoU operon to cell adherence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium. Infect Immun (2009) 0.95
Pneumococcal meningitis: development of a new animal model. Otol Neurotol (2006) 0.94
Different bacterial pathogens, different strategies, yet the aim is the same: evasion of intestinal dendritic cell recognition. J Immunol (2010) 0.94
The major surface-associated saccharides of Klebsiella pneumoniae contribute to host cell association. PLoS One (2008) 0.93
Transcriptional analysis of the grlRA virulence operon from Citrobacter rodentium. J Bacteriol (2010) 0.93
Molecular epidemiology of Streptococcus pneumoniae serogroup 6 isolates from Fijian children, including newly identified serotypes 6C and 6D. J Clin Microbiol (2010) 0.92
Reactive oxygen species are the major antibacterials against Salmonella Typhimurium purine auxotrophs in the phagosome of RAW 264.7 cells. Cell Microbiol (2007) 0.90
A bioinformatic strategy for the detection, classification and analysis of bacterial autotransporters. PLoS One (2012) 0.90
Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine. J Virol (2002) 0.89
Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A. Innate Immun (2012) 0.89
Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome. PLoS Pathog (2012) 0.89
Poly-immunoglobulin receptor-mediated transport of IgA into the male genital tract is important for clearance of Chlamydia muridarum infection. Am J Reprod Immunol (2008) 0.88
Transcriptional activation of the mrkA promoter of the Klebsiella pneumoniae type 3 fimbrial operon by the c-di-GMP-dependent MrkH protein. PLoS One (2013) 0.88
Detection of enterohaemorrhagic Escherichia coli in patients attending hospital in Melbourne, Australia. Pathology (2004) 0.88
Assessment of the protective effect of pneumococcal vaccination in preventing meningitis after cochlear implantation. Arch Otolaryngol Head Neck Surg (2007) 0.87
Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis. Otolaryngol Head Neck Surg (2007) 0.87
Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium. Vaccine (2006) 0.86
Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota. Pediatr Allergy Immunol (2011) 0.86
Appetising solutions: an edible vaccine for measles. Med J Aust (2002) 0.86
Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG. BMC Res Notes (2013) 0.84
In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium. FEMS Immunol Med Microbiol (2003) 0.84
Restriction of DNA encoding selectable markers decreases the transformation efficiency of Helicobacter pylori. FEMS Immunol Med Microbiol (2005) 0.84
Using bioluminescent imaging to investigate synergism between Streptococcus pneumoniae and influenza A virus in infant mice. J Vis Exp (2011) 0.84
Can we prevent cochlear implant recipients from developing pneumococcal meningitis? Clin Infect Dis (2008) 0.84
Bacterial antigen expression is an important component in inducing an immune response to orally administered Salmonella-delivered DNA vaccines. PLoS One (2009) 0.83
Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections. Vaccine (2008) 0.83
Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse. Immunol Res (2004) 0.83
CD8+ T cells are associated with severe gastritis in Helicobacter pylori-infected mice in the absence of CD4+ T cells. Infect Immun (2007) 0.82
Induction of CD8+ T lymphocytes by Salmonella typhimurium is independent of Salmonella pathogenicity island 1-mediated host cell death. J Immunol (2002) 0.82